These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15166203)

  • 41. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 42. Hormone replacement therapy.
    Rosenblatt J; Murtagh J
    Aust Fam Physician; 1992 Sep; 21(9):1345-6. PubMed ID: 1417565
    [No Abstract]   [Full Text] [Related]  

  • 43. Helping women stop postmenopausal hormone therapy.
    Grady D
    Menopause; 2006; 13(3):323-4. PubMed ID: 16735925
    [No Abstract]   [Full Text] [Related]  

  • 44. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hormone replacement therapy and ischemic heart disease--a dangerous cocktail? Changes in the collected evidence].
    Lassen PD; Stender S
    Ugeskr Laeger; 2003 Oct; 165(41):3909-13. PubMed ID: 14579550
    [No Abstract]   [Full Text] [Related]  

  • 46. Hormone therapy and breast cancer: what factors modify the association?
    Gertig DM; Fletcher AS; English DR; Macinnis RJ; Hopper JL; Giles GG
    Menopause; 2006; 13(2):178-84. PubMed ID: 16645531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term use of progestogens: colon adenoma and colon carcinoma.
    Schindler AE
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():42-4. PubMed ID: 17943538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Migraine and the menopause.
    MacGregor EA
    J Br Menopause Soc; 2006 Sep; 12(3):104-8. PubMed ID: 16953983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen and progestogens--different routes of administration.
    Sitruk-Ware R
    Climacteric; 2005 Aug; 8 Suppl 1():1-2. PubMed ID: 16112946
    [No Abstract]   [Full Text] [Related]  

  • 50. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. United States regulatory considerations for intrauterine progestins for hormone replacement therapy.
    Rarick L
    Contraception; 2007 Jun; 75(6 Suppl):S140-3. PubMed ID: 17531606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone replacement therapy in Denmark, 1995-2004.
    Løkkegaard E; Lidegaard O; Møller LN; Agger C; Andreasen AH; Jørgensen T
    Acta Obstet Gynecol Scand; 2007; 86(11):1342-51. PubMed ID: 17963062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone therapy: making decisions in the face of uncertainty.
    Peterson HB; Thacker SB; Corso PS; Marchbanks PA; Koplan JP
    Arch Intern Med; 2004 Nov; 164(21):2308-12. PubMed ID: 15557408
    [No Abstract]   [Full Text] [Related]  

  • 55. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormone replacement therapy aggravates postmenopausal urinary incontinence.
    Prescrire Int; 2006 Aug; 15(84):137-8. PubMed ID: 16989027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risk and hormone replacement therapy.
    Lawlor DA; Smith GD
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):658-65. PubMed ID: 17099339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Commentary: hormones, heart disease, and the definition of hormone 'initiation'.
    Stampfer MJ
    Int J Epidemiol; 2006 Jun; 35(3):738-9; discussion 740. PubMed ID: 16581820
    [No Abstract]   [Full Text] [Related]  

  • 60. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.